As of 14 Oct 2026, Kriya Therapeutics has raised $320M across 1 verified round on record; latest: $320m Series D led by Patient Square Capital and Premji Invest, announced 11 Sep 2025.
Kriya Therapeutics develops durable medicines aimed at treating chronic diseases with one-time administration.
kriyatx.comLinkedInBiotech
1 source
The source identifies several additional long-standing backers but does not name them; they are therefore not listed.; not on the page it cites, so not applied: date
Published by hand (pharmaceutical-technology.com): "Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m...": biggest-rounds completeness (K): hand-checked, the cited page states $320m
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series D [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $320M | 2025-09-11 | Patient Square Capital, Premji Invest | No recent discussion |
1 source [ VERIFIED ] read against 1 source The source identifies several additional long-standing backers but does not name them; they are therefore not listed.; not on the page it cites, so not applied: date Published by hand (pharmaceutical-technology.com): "Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m...": biggest-rounds completeness (K): hand-checked, the cited page states $320m | ||||